Formula: | C17H19N3O4S2 |
Molecular Weight: | 393.49 |
Rotatable Bond Donors: | 6 |
clogP: | 1.63 |
Topological Polar Surface Area: | 88.60 |
Lipinski's RO5: | MW: 393.49 HBA: 7 HBD: 1 RB: 6 LogP: 1.63 |
Rule of Three: | MW: 393.49 HBA: 7 HBD: 1 RB: 6 LogP: 1.63 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS31704 | 0.73 | EOS31704 RDKit 3D 27 30 0 0 0 0 0 0 0 0999 V2000 0.0758 1.5371 2.0071 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7008 1.7488 0.9669 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1663 1.3387 -0.4026 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.3498 1.5004 -0.3910 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8709 0.1802 -0.8915 C 0 0 2 0 0 0 0 0 0 0 0 0 -3.2196 -0.1089 -0.5800 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.5713 -0.2517 0.7287 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7096 -0.1720 1.8133 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1887 -0.3355 3.1073 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.5420 -0.5820 3.2645 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.4184 -0.6751 2.2412 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.9090 -0.5043 1.0003 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8395 -0.8516 -0.4941 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4512 -0.1240 -0.5861 N 0 0 0 0 0 0 0 0 0 0 0 0 1.2905 -0.4209 -2.0270 S 0 0 0 0 0 0 0 0 0 0 0 0 2.5206 0.3385 -2.0026 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3382 -0.2660 -3.1058 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7726 -2.1158 -2.0601 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6373 -3.0958 -3.0175 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1835 -4.3355 -2.6126 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7204 -4.2546 -1.3570 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5740 -2.7133 -0.6659 S 0 0 0 0 0 0 0 0 0 0 0 0 1.9361 2.3438 0.9642 N 0 0 0 0 0 0 0 0 0 0 0 0 2.5814 2.7231 2.1952 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9979 3.0950 1.7972 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9262 3.4022 0.3106 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7461 2.5990 -0.2027 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 3 2 1 1 3 4 1 0 4 5 1 0 5 6 1 1 6 7 1 0 7 8 2 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 2 0 5 13 1 0 13 14 1 0 14 15 1 0 15 16 2 0 15 17 2 0 15 18 1 0 18 19 2 0 19 20 1 0 20 21 2 0 21 22 1 0 2 23 1 0 23 24 1 0 24 25 1 0 25 26 1 0 26 27 1 0 14 3 1 0 22 18 1 0 27 23 1 0 12 7 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |